Position in HALO
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$704
+$123 QoQ
Shares Held
9
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#645
of 664 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MOTCO holds $54,760 across 13 Biotechnology names. HALO ranks #5 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RANI |
Rani Therapeutics Holdings, Inc.
|
48,129 | $36,597 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
19 | $9,437 | |
| 3 | ARGX |
Argenx SE
|
3 | $2,783 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3 | $1,870 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
This page
|
9 | $704 | |
| 6 | GMAB |
Genmab A/S
|
22 | $604 | |
| 7 | MRNA |
Moderna, Inc.
|
7 | $490 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
2 | $481 |
All Filings in HALO
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $704 | 9 | Shares | Defined | 2026-07-31 | |
| 2026-03-31 | $581 | 9 | Shares | Defined | 2026-04-22 | |
| 2025-12-31 | $605 | 9 | Shares | Defined | 2026-02-06 | |
| 2025-09-30 | $660 | 9 | Shares | Defined | 2025-10-22 | |
| 2025-06-30 | $468 | 9 | Shares | Defined | 2025-08-01 | |
| 2025-03-31 | $574 | 9 | Shares | Defined | 2025-05-07 | |
| No filing history on record for this holder in this stock. | ||||||